Kyle McKey
Cornea and External Diseases Specialist · Grand Rapids, MINPI 1205360062
Payments from drug & device makers
Across 24 payments — averaging $98.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$722
- Glaukos Corporation$496
- Novartis$226
- Alcon Research LLC$156
- Oyster Point Pharma, Inc.$154
- Johnson & Johnson Surgical Vision, Inc.$136
- plus $474 from 6 others
What the payments were for
- Food & beverage$2,365100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 8 | $722 |
| Glaukos Corporation | 4 | $496 |
| Novartis | 2 | $226 |
| Alcon Research LLC | 1 | $156 |
| Oyster Point Pharma, Inc. | 1 | $154 |
| Johnson & Johnson Surgical Vision, Inc. | 2 | $136 |
| Eyepoint US, Inc. | 1 | $124 |
| Mallinckrodt Hospital Products Inc. | 1 | $106 |
| Carl Zeiss Meditec Cataract Technology Inc. | 1 | $106 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $100 |
| Biotissue Holdings Inc. | 1 | $20 |
| Amgen | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- iStent inject W$419
- iStent$297
- KXL System$297
- IACCESS$188
- Photrexa$188
- AIR OPTIX$156
- TYRVAYA$154
- Clareon$143
- AcrySof IQ PanOptix$128
- YUTIQ$124
- Tecnis IOL$114
- Tecnis Simplicity$114
- XIIDRA$106
- ACTHAR$106
- VYZULTA$100
How this compares
Too few cornea and external diseases specialist providers in Michiganto place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Prednisolone Acetate | 356 | $10,518 |
| Fluorometholone | 70 | $6,058 |
| ValacyclovirValacyclovir Hcl | 54 | $3,349 |
| MoxifloxacinMoxifloxacin Hcl | 116 | $2,076 |
| ErythromycinErythromycin Base | 56 | $692 |
| Polymyxin B Sul-TrimethoprimPolymyxin B Sulf/Trimethoprim | 72 | $528 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 22 | $474 |
| Ketorolac Tromethamine | 27 | $420 |
| Timolol Maleate | 26 | $228 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 12 | $153 |
| Doxycycline Hyclate | 12 | $138 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 30 | $44 |
Paid to pharmacies, not to this prescriber.
Other cornea and external diseases specialist in Grand Rapids
- Christopher ChowMadison Heights$123K
- Ayad FarjoBrighton$218
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.